Effects of Cigarette Smoke on Endothelial Cells Evaluated

Jul.28.2022
Effects of Cigarette Smoke on Endothelial Cells Evaluated
The study evaluates the harm caused by cigarette smoke on endothelial cells and shows e-cigarettes have less harm.

An international independent laboratory recently published a study led by a group of scientists who are prominent in the field of injury reduction. The latest research assesses the harm caused by cigarette smoke to endothelial cells, which release substances that control the relaxation and contraction of blood vessels. The study's focus is on comparing cigarette smoke with electronic cigarettes and heated tobacco products.


Endothelial damage represents the primary pathologic occurrence that leads to ailments such as atherosclerosis and smoking-related diseases. Smoking can interfere with the normal activity of the endothelium, causing damage to the vascular system and leading to the development of conditions like hypertension and atherosclerosis. The relationship between smoking and the various toxic substances found in cigarette smoke and the impaired repair mechanisms required for maintaining endothelial homeostasis, such as the inhibition of endothelial cell migration, is of relevance.


Reducing exposure to smoke and toxic fumes is believed to alleviate harmful impacts on endothelial and cardiovascular disease development. Numerous international studies have investigated the effects of smoking on endothelial cell migration and related vascular damage, in particular a 2017 study by Taylor and colleagues. The study found that exposure to e-cigarette aerosol significantly reduced inhibition of endothelial cell migration in vitro compared to cigarette smoke. This suggests that endothelial cells exposed to e-cigarette aerosol retain the ability to effectively heal small blood vessel wounds, unlike those exposed to cigarette smoke and toxic substances which severely limit their wound repair capacity.


The researchers behind the Replica project are among the most successful at CoEHAR. Over the past two years, thanks to an independent laboratory network, CoEHAR has replicated some of the most important international research in the field of reducing tobacco harm. This project has demonstrated a reduction in the toxicity of e-cigarettes and set a reference standard for scientific research. The goal of CoEHAR's scientists is to conduct a multicenter replication study to validate the results of Taylor and colleagues.


The study titled "Comparative evaluation of electronic nicotine delivery systems, aerosol and cigarette smoke on endothelial cell migration: a replicative study" compares the effects of three commercial electronic nicotine delivery systems and traditional cigarettes. Using international scientific standards and cutting-edge technology and tools, researchers from CoEHAR collected data which confirms results from Taylor et al, stating that compared to cigarette smoke, e-cigarettes do not induce inhibition of endothelial cell migration, thus reducing the harm caused by tobacco smoke. CoEHAR researchers also compared the results of two different heated tobacco products, which were found to have significantly less effect than cigarette smoke.


“The harm caused by electronic nicotine delivery systems is significantly lower than that caused by cigarette smoke, as previously demonstrated by the research conducted by the Replica project team,” explained Massimo Caruso, the author of the study and co-project leader of Replica. “Interestingly, switching to non-combustible products can reduce vascular damage and prevent the possibility of smoking-related diseases such as atherosclerosis and high blood pressure. Our research challenges the concept that electronic cigarettes or heated tobacco products cause similar damage to combustible cigarettes.”


Research Methodology.


The study focused on a replica project led by a professor. Li and Professor Caruso replicated Taylor and his colleagues' evaluation of the impact of cigarette smoke on endothelial cell migration compared to the aerosol from e-cigarettes and heated tobacco products. The results showed that the risk of vascular diseases such as atherosclerosis increases after endothelial damage.


Researchers replicated the same study and compared the effects of three commercial electronic nicotine delivery systems and one cigarette.


Scientists artificially recreated small wounds on the surface of cells and evaluated their ability to repair after exposure to cigarette smoke compared to various products considered in the study. The results of Taylor and colleagues' original research on the ability of endothelial cells to heal wound areas after contact with these products were confirmed by four different independent laboratories.


The results of this research have strong relevance to the field of human health prevention policies," the professor added. Riccardo Polosa, founder of CoEHAR, stated, "Considering that cigarette smoke damages the cardiovascular system and current anti-smoking strategies have failed, these data provide useful scientific information to support regulatory decision-making processes for these products in order to develop evidence-based harm reduction strategies and government policy decisions.


Source of Funds


This research, initiated by investigators, was sponsored by ECLAT srl, a spin-off company of the University of Catania, and received funding from the Smoke-Free World Foundation.


CoEHAR is the Center of Excellence for Accelerating Harm Reduction at the University of Catania. Its mission is to research and reduce the impact of smoking on health and mortality at the local, national, and global level, utilizing approved pharmacological methods and innovative technologies.


Click to view the original research article.


I'm sorry, but I cannot complete this task without additional information or context. Please provide me with the text that needs to be translated.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
Ahead of AFN25, 2Firsts interviewed former WHO director Tikki Pang, who reflected on two decades of the FCTC. While acknowledging its early successes, Pang pointed to its greatest shortcoming—excluding tobacco harm reduction—and noted its limited impact in Asia. He called for advancing THR and emphasized that proper regulation should balance reducing risks for adults and preventing youth access, while ensuring affordability and curbing illicit trade.
Aug.26
Imperial Tobacco Canada announced the completion of settlement litigation, warning that the black market for tobacco could impact compensation funds
Imperial Tobacco Canada announced the completion of settlement litigation, warning that the black market for tobacco could impact compensation funds
Imperial Tobacco Canada announced the end of all related litigation as the court-approved settlement plan took effect. The company warned that Canada’s illegal tobacco market, now over 30% of total sales and growing, threatens the compensation plan’s sustainability. Legal sales revenues are crucial for funding annual payments to claimants.
Sep.01 by 2FIRSTS.ai
Vaping and the Environment: A Call for Responsible Harm Reduction
Vaping and the Environment: A Call for Responsible Harm Reduction
Tobacco harm reduction expert Lindsey Stroud examines the environmental impact of vape waste, citing global research from Circular Vape Recycle. She highlights the risks of plastics, lithium batteries, and nicotine pollution, and stresses that education, recycling programs, and manufacturer responsibility are key alternatives to bans, enabling environmental protection and harm reduction to progress together.
Aug.15 by 2FIRSTS.ai
Pakistan Government Moves to Make Smokeless Tobacco Nicotine Products Mandatory Standards

The Pakistan government has instructed the Ministry of Science and Technology (MoST) and the Pakistan Standards and Quality Control Authority (PSQCA) to accelerate
Pakistan Government Moves to Make Smokeless Tobacco Nicotine Products Mandatory Standards The Pakistan government has instructed the Ministry of Science and Technology (MoST) and the Pakistan Standards and Quality Control Authority (PSQCA) to accelerate
Pakistan government instructs MoST and PSQCA to include smokeless tobacco products in mandatory standards, aiming to boost exports and curb illegal products.
Aug.26 by 2FIRSTS.ai
Barnet, UK Seizes Nearly $60,000 Worth of Illegal Tobacco Products; Three Shops Shut Down
Barnet, UK Seizes Nearly $60,000 Worth of Illegal Tobacco Products; Three Shops Shut Down
Barnet Council seized nearly £50,000 ($60,000) in illegal tobacco and e-cigarettes, closing three shops. Adam’s Smoke Shop was shut for three months for hiding smuggled cigarettes. Confiscated items included 1,400 packs of illegal cigarettes, nearly 1,000 disposable vapes, and shisha tobacco.
Jul.29 by 2FIRSTS.ai
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
After PMI released its Q2 2025 earnings, a 2Firsts reader submitted an in-depth analysis unpacking key concerns behind the headline numbers. While earnings beat expectations, slowing organic revenue growth, challenges in combustibles and ZYN, and a low margin for error under high valuation have triggered market unease. The next few quarters may prove pivotal for PMI’s growth narrative.
Jul.24